Thus, the PI3K/Akt pathway may enhance Chk1 activation also in hematopoietic cells under some circumstances, although under the conditions more relevant to treatment of leukemia its inhibition downregulated Chk1 activation and G2/M checkpoint to enhance apoptosis. The gene discussed is CHEK1; the disease is leukemia.